Anne Marie‐Cardine

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial

M. Bagot, Pierluigi Porcu, Anne Marie‐Cardine et al. · The Lancet Oncology · 2019 · 157 citations · Full text

Medicine, Hematology, Oncology +13

The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages

Deborah S. Black, Anne Marie‐Cardine, Burkhart Schraven et al. · Cellular Microbiology · 2000 · 139 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity

Philippe Le Bouteiller, Alíz Barakonyi, Jérôme Giustiniani et al. · Proceedings of the National Academy of Sciences · 2002 · 135 citations

Life Sciences, Cell Biology, Immunology +17

T Cell Receptor (TCR) Interacting Molecule (TRIM), A Novel Disulfide-linked Dimer Associated with the TCR–CD3–ζ Complex, Recruits Intracellular Signaling Proteins to the Plasma Membrane

Eddy Bruyns, Anne Marie‐Cardine, Henning Kirchgessner et al. · The Journal of Experimental Medicine · 1998 · 125 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages

John F. Timms, Kenneth D. Swanson, Anne Marie‐Cardine et al. · Current Biology · 1999 · 111 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12